[ad_1]
According to Reuters, nearly one million people have received an experimental coronavirus vaccine developed by the China National Pharmaceutical Group (Sinopharm) as part of a national immunization campaign for essential workers, Chinese officials said.
China launched the emergency use program in July, which so far includes three vaccines for essential workers and other limited groups of people, although clinical trials have not yet been completed to prove their safety and efficacy.
However, no serious adverse reactions were reported from those who received the vaccine, Sinopharm says in an article on the WeChat social network, citing the company’s president, Liu Jingzhen.
Two vaccines developed by Sinopharm and one vaccine by Sinovac Biotech were used for the emergency vaccination program.
The experimental vaccines are in phase 3 clinical trials overseas and have been used by nearly 60,000 people, and blood samples from more than 40,000 participants have already been taken 14 days after taking the second dose, he said. Liu Jingzhen.
Read also Sinovac Chinese Vaccine, a fast but low-antibody immune response
Publisher: RK
.
[ad_2]
Source link
